Boris Juelg, M.D., Ph.D.Principal Investigator and CTU Principal Investigator
Clinical Trials Unit
Assistant Professor of Medicine, Harvard Medical School
Physician, Division of Infectious Diseases at Massachusetts General Hospital (MGH)
Associate Member of the Ragon Institute of MGH, MIT and Harvard.
As a physician-scientist, Dr. Juelg aims to link preclinical and clinical studies to identify and test the most promising immunological strategies to prevent and treat HIV infection. He is specifically interested in evaluating passive and active immunization approaches using broadly neutralizing antibodies and novel vaccine candidates. In close collaboration with other investigators at the Ragon Institute, Dr. Juelg is conducting phase I/II clinical trials that are testing such concepts and translating findings from the lab into the clinic.
Christian Albrecht University, M.D., PhD.
Dr. Juelg received an MD and PhD from Christian Albrecht University in Kiel, Germany. He completed a postdoctoral research fellowship with Dr. Bruce Walker before undergoing internal medicine training at MGH and a fellowship in infectious diseases through the combined program at MGH and Brigham and Women’s Hospital.
He is a member of the AIDS Clinical Trials Group (ACTG) Cure Transformative Science Group (TSG) and a member of the MGH Committee for Clinical Research.